Case Study: QPCTL is a Small Molecule Drug Target Modulating the Innate Immune Response

Time: 3:00 pm
day: Day One

Details:

  • Introduction into the Cell-Seq platform to identify novel drug targets
  • Identification of QPCTL as a new target that impacts CD47 and several chemokines
  • Preclinical evaluation of QPCTL inhibition